Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa

BACKGROUND: Data on safety and efficacy of second-line tuberculosis drugs in pregnant women and their infants are severely limited due to exclusion from clinical trials and expanded access programs. METHODS: Pregnant women starting treatment for multidrug/rifampicin-resistant (MDR/RR)-tuberculosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Loveday, Marian, Hughes, Jennifer, Sunkari, Babu, Master, Iqbal, Hlangu, Sindisiwe, Reddy, Tarylee, Chotoo, Sunitha, Green, Nathan, Seddon, James A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028100/
https://www.ncbi.nlm.nih.gov/pubmed/32141495
http://dx.doi.org/10.1093/cid/ciaa189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028100/
https://www.ncbi.nlm.nih.gov/pubmed/32141495
http://dx.doi.org/10.1093/cid/ciaa189

Ejemplares similares